NFE2L2 and neoplasm: In addition, activation of the nuclear factor erythroid 2-related factor 2 (NRF2) signaling is involved in the development of chemoresistance and melatonin upregulates NRF2 through its specific receptors MT1 and MT2, SIRT1 and PI3K/Akt pathways in non-tumor cells.